Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Invitae Corp NVTAQ

Healthcare
Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services, digital health solutions, and health data services that support a lifetime of patient care and improved outcomes. It offers genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. It applies... see more

Recent & Breaking News (GREY:NVTAQ)

Invitae to Present at the Bank of America Merrill Lynch 2017 Health Care Conference

PR Newswire April 27, 2017

Invitae to Announce First Quarter 2017 Financial Results and Host Conference Call on May 8, 2017

PR Newswire April 24, 2017

Invitae announces expansion of its genetic test menu with addition of new tests and expanded panels for inherited metabolic and immune system disorders, including panels to confirm diagnoses suggested by newborn screening

PR Newswire April 20, 2017

Invitae expands its Genome Network with the launch of the Invitae Patient Insights Network (PIN), enabling participants to share health information and contribute to research

PR Newswire April 6, 2017

Invitae announces new partnership with Alnylam Pharmaceuticals to provide TTR gene testing for patients suspected of having hereditary ATTR amyloidosis

PR Newswire April 3, 2017

Invitae announces introduction of exome testing

PR Newswire March 30, 2017

Invitae Expands Test Menu for Proactive Genetic Testing in Healthy Adults

PR Newswire March 23, 2017

Invitae announces expansion of its genetic testing offering to include unique test for Spinal Muscular Atrophy (SMA) during the 2017 ACMG Annual Clinical Genetics Meeting

PR Newswire March 22, 2017

Invitae to present seventeen posters and presentations at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting

PR Newswire March 14, 2017

Invitae to present at the Cowen and Company 37th Annual Health Care Conference

PR Newswire February 21, 2017

New research suggests broader genetic testing of prostate cancer patients may be warranted to identify risk of an inherited mutation that might inform treatment

PR Newswire February 17, 2017

Invitae reports revenue of $9.2 million in fourth quarter 2016 and projects strong volume and revenue growth in 2017

PR Newswire February 13, 2017

Invitae to announce fourth quarter and year-end 2016 financial results and 2017 guidance and will host conference call on February 13, 2017

PR Newswire January 30, 2017

Research Reports Initiation on Healthcare Stocks -- PAREXEL, Charles River Laboratories, PRA Health Sciences, and Invitae

PR Newswire January 19, 2017

Invitae announces new leadership structure to drive global growth

PR Newswire January 9, 2017

Invitae meets annual volume guidance, projects doubling of volume in 2017, accelerates Genome Network by acquiring scalable patient-centered data company

PR Newswire January 6, 2017

Invitae acquires patient-centered data company AltaVoice, creating new offerings to advance research and access to care for patients with inherited and rare diseases

PR Newswire January 6, 2017

Invitae to present at the 35th Annual J.P. Morgan Healthcare Conference

PR Newswire December 28, 2016

Invitae announces major expansion of its pediatric, neurological, and rare disease genetic test offerings

PR Newswire December 21, 2016

InVitae Execs Talk Genetics And Growth

Benzinga.com  December 16, 2016